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Background: Although engineered nanomaterials (ENM) are currently regulated either in the context of a new
chemical, or as a new use of an existing chemical, hazard assessment is still to a large extent reliant on information
from historical toxicity studies of the parent compound, and may not take into account special properties related to
the small size and high surface area of ENM. While it is important to properly screen and predict the potential
toxicity of ENM, there is also concern that current toxicity tests will require even heavier use of experimental
animals, and reliable alternatives should be developed and validated. Here we assessed the comparative respiratory
toxicity of ENM in three different methods which employed in vivo, in vitro and ex vivo toxicity testing approaches.
Methods: Toxicity of five ENM (SiO2 (10), CeO2 (23), CeO2 (88), TiO2 (10), and TiO2 (200); parentheses indicate
average ENM diameter in nm) were tested in this study. CD-1 mice were exposed to the ENM by oropharyngeal
aspiration at a dose of 100 μg. Mouse lung tissue slices and alveolar macrophages were also exposed to the ENM
at concentrations of 22–132 and 3.1-100 μg/mL, respectively. Biomarkers of lung injury and inflammation were
assessed at 4 and/or 24 hr post-exposure.
Results: Small-sized ENM (SiO2 (10), CeO2 (23), but not TiO2 (10)) significantly elicited pro-inflammatory responses in mice
(in vivo), suggesting that the observed toxicity in the lungs was dependent on size and chemical composition. Similarly,
SiO2 (10) and/or CeO2 (23) were also more toxic in the lung tissue slices (ex vivo) and alveolar macrophages (in vitro)
compared to other ENM. A similar pattern of inflammatory response (e.g., interleukin-6) was observed in both ex vivo and
in vitro when a dose metric based on cell surface area (μg/cm2), but not culture medium volume (μg/mL) was employed.
Conclusion: Exposure to ENM induced acute lung inflammatory effects in a size- and chemical composition-dependent
manner. The cell culture and lung slice techniques provided similar profiles of effect and help bridge the gap in
our understanding of in vivo, ex vivo, and in vitro toxicity outcomes.
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It is well recognized that nanotechnology has been rap-
idly growing and advancing over the past 10 years, and
will continue to expand in numerous market sectors
[1,2]. The advances in nanotechnology, however are
accompanied by a need for better understanding of the
exposure and toxicity of engineered nanomaterials (ENM)
across their life-cycle. Moreover, the enormously diverse* Correspondence: gilmour.ian@epa.gov
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unless otherwise stated.and applications of ENM (e.g., shapes, sizes, chemical and
surface characteristics) are likely to result in a broad array
of exposures and potentially adverse health outcomes.
Thus, methods to evaluate and predict the toxicity of
ENM are of considerable importance [3]. In particular,
more information is needed on the interactions of ENM
with lung tissue, since inhalation is a common exposure
route and can also lead to potential systemic toxicity [1].
There is already substantial epidemiologic and toxico-
logical evidence that inhaled ENM cause pulmonary effects
(e.g., inflammation and/or edema) and/or extrapulmonary
or systemic effects (e.g., thrombosis, dysrhythmias, and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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studies of the respiratory tract are performed with in vivo
(e.g., mice and rats) or in vitro (e.g., airway/alveolar epi-
thelial cells, macrophages, and dendritic cells) models.
Because of the inherent anatomical complexity of the
intact lung which is comprised of about 40 different cell
types interpretation of toxicity of ENM in in vitro cell
culture models is limited as they do not reflect the com-
plex cell-cell contacts and cell-matrix interactions in the
tissue. Moreover, despite the need for studying the toxicity
of ENM in vivo, there is a growing concern that broad tox-
icity testing will increase the number of animals required.
Therefore, developing credible alternative testing methods
predictive of in vivo ENM toxicity are essential to screen
potential hazards and health risks associated with inhal-
ation exposures to these novel materials [2].
Here, we investigated pulmonary toxicity of five ENM:
one silicon dioxide (SiO2), two cerium oxide (CeO2), and
two titanium dioxide (TiO2) nanomaterials with different
primary diameters. SiO2, CeO2, and TiO2 nanomaterials
are already widely used in industrial processes and con-
sumer products. CeO2 and TiO2 nanomaterials are the
most abundantly produced metal oxide nanomaterials in
the U.S. [8] and have been independently tested for ad-
verse health effects in vitro and in vivo, but not in the
same study design [9,10]. CeO2 nanomaterials are of inter-
est because despite having the same crystalline form as
the parent compound, the nano-sized material causes
more oxidative stress as a result of subtle changes in their
surface chemistry [11,12]. SiO2 nanomaterials (particularly
the amorphous form), have also recently received atten-
tion in biomedical applications, yet their toxicity is not
fully understood [13]. In the present study, we conducted
acute toxicity tests in mice (in vivo), mouse lung tissue
slices (ex vivo), and mouse alveolar macrophages (in vitro)
to extrapolate, and compare the results between ex vivo or
in vitro to in vivo toxicity testing approaches. Lung tissue
slices have shown to preserve almost all cell types and
interactions with the microenvironment (i.e., cell-cell or
cell-matrix interactions), thus providing the most in vivo-
like physiologically relevant response. Of all the different
types of lung cells, alveolar macrophages are considered
to be one of the first lines of a defense against inhaled
particles and are primarily responsible for producing pro-
inflammatory mediators [14]. The specific aims of this
study were to determine the pulmonary toxicity and pro-
inflammatory potential of ENM in mice, and compare
these effects with the use of ex vivo lung slice and in vitro
cell-based toxicity testing systems.
Results
Particle size distributions of ENM
Hydrodynamic diameters of ENM in the various solu-
tions used in this study were determined by dynamiclight scattering (Table 1). Diameters of all ENM suspended
in water were greater than the specifications provided by
the manufacturer, and were even larger when the mate-
rials were suspended in culture media. Of all the ENM
studied, TiO2 (10) and SiO2 (10) were the most highly
agglomerated. Since this clumping behavior controls the
density of the ENM agglomerates in suspensions, we esti-
mated the agglomerate density and presented the results
in Table 1. SiO2 (10) had the lowest agglomeration density
in any solution, indicating that this material was most
likely to remain suspended in the solutions and less likely
to interact with the cells. Agglomerated TiO2 (200), on
the other hand had the highest density which would pro-
mote settling and a greater potential to come in contact
with the cells on the plate bottom.
Pulmonary inflammation responses in vivo
We monitored concentrations of lactate dehydrogenase
(LDH) released into bronchoalveolar lavage fluid (BALF)
at 4 hr and 24 hr post-exposure as a biomarker for lung
cell injury. None of the ENM, except for CeO2 (88) (at
24 hr post-exposure), significantly increased the concen-
trations of LDH at any time point compared with saline
control groups (Figure 1A). N-acetyl-β-D-glucosaminidase
(NAG) and γ-glutamyl transferase (GGT) as biomarkers
for lysosomal enzyme and oxidative stress, respectively,
were also assessed and were unchanged for any of the
ENM (data not shown). Concentrations of albumin and
total protein in BALF from the CeO2 (23)-exposed groups
were significantly increased at 4 hr and 24 hr post-
exposure compared with saline-exposed groups, indicating
that this material caused lung edema (Figure 1B and C).
As a positive control, LPS increased LDH, albumin, and
protein as expected, but did not affect NAG or GGT. The
size- and composition-dependent toxicity of ENM was
also seen in pulmonary inflammatory cells at 4 hr and
24 hr post-exposure (Figure 2). The CeO2 (23)-exposure
groups significantly increased the number of neutrophils
(18% and 34% at 4 hrs and 24 hrs, respectively), compared
with saline controls. While LPS-exposure groups induced
an even stronger neutrophil influx, no other ENM
caused significant changes in the neutrophil number.
The number of macrophages in BALF was unchanged
by any treatment.
Concentrations of pro-inflammatory cytokines (inter-
leukin-6 (IL-6), macrophage inhibitory protein-2 (MIP-2),
and tumor necrosis factor-α (TNF-α)) were then moni-
tored in BALF at both time-points (Figure 3). CeO2 (23)
significantly increased the concentrations of all three cyto-
kines at 4 hr post-exposure compared with saline control
groups. SiO2 (10) significantly increased the concentra-
tions of IL-6 and MIP-2 at 4 hr post-exposure, while TiO2
(10) but not the TiO2 (200) only increased the concentra-
tion of MIP-2. These data indicate that the small-sized











Agglomerate densityg (g/cm3) Crystal
formWater Saline CMc CMc CMc
(ex vivo)
CMc
(in vitro)(in vivo) (ex vivo) (in vitro)
SiO2 SiO2 (10) 5-15
a 401 ± 13 574 ± 96 458 ± 66 342 ± 44 590-690a 2.65 3.54 1.06 ± 0.01 1.07 ± 0.01 Amorphous
CeO2 CeO2 (23) 15-30
a 131 ± 55 269 ± 91 796 ± 46 432 ± 133 30-50a 7.22 20.79 1.49 ± 0.03 1.88 ± 0.45 Cerianite
CeO2 CeO2 (88) 70-105
a 162 ± 60 239 ± 52 500 ± 38 220 ± 31 8-12a 7.22 83.16 2.78 ± 0.18 4.23 ± 0.58 Cerianite
TiO2 TiO2 (10) 10
a 402 ± 16 739 ± 10 645 ± 3 660 ± 62 100-130a 3.90 12.33 1.19 ± 0.00 1.19 ± 0.02 Anatase
TiO2 TiO2 (200) 200
a 387 ± 12 690 ± 29 493 ± 6 417 ± 22 6.99d 3.90 202.92 2.65 ± 0.03 2.86 ± 0.12 Anatase
aprovided by the manufacturer.
bdetermined by dynamic light scattering and expressed as mean ± SEM of multiple measurements.
cCM: culture medium.
dobtained from Sanders et al. [15].
eobtained from the CRC Handbook of Chemistry and Physics [16].
fcalculated from equivalent primary diameter =6/(SSA × ρ) [17,18], where SSA is specific surface area, and ρ is raw nanomaterial density.
gcalculated from the Sterling equation [19], agglomerate density = (1-(1-(dH/dEq)
DF-3))ρ + (1-(dH/dEq)
DF-3)ρmedia, where dH is hydrodynamic diameter, dEq is equivalent primary diameter, DF is theoretical fractal dimension

















Figure 1 Biochemical markers for lung injury and edema in BALF of mice at 4 hr and 24 hr post-exposure to ENM (100 μg) by oropharyngeal
aspiration. (A) LDH, (B) albumin, and (C) total protein concentrations in BALF. Data are means ± SEM (n =5-6 in each group). *p <0.05 compared with
the saline-exposed negative control group from the same time point. Mice exposed to 2 μg of LPS served as a positive control.
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larger counterparts, and that chemical composition of
ENM was a more important determinant than their size.
Based on the cytokine response results, toxicity ranking of
ENM approximated CeO2 (23) ≈ SiO2 (10) > TiO2 (10) >
CeO2 (88) > TiO2 (200). At 24 hr post-exposure, the
cytokine concentrations decreased to saline control values
except for CeO2 (23) which maintained elevated levels of
IL-6 and TNF-α. Interestingly, the inflammation was not
related to uptake of ENM in lung macrophages. The less
active TiO2 (10) and TiO2 (200) were avidly taken up by
lung macrophages at both time points compared withFigure 2 Number of neutrophils and macrophages in BALF of mice at
aspiration. (A) neutrophils and (B) macrophages. Data are means ± SEM (n
negative control group from the same time point. Mice exposed to 2 μg oother ENM (Additional file 1: Figure S1). Finally, there
were no significant changes in circulating white blood
cells, red blood cells (RBCs) or RBC indices between the
ENM-exposed mice and saline controls (data not shown).
Pulmonary inflammation responses ex vivo and in vitro
LDH, GGT, and NAG concentrations in the supernatants
from the lung tissue slices at 24 hr post-exposure were
unchanged at any of the concentrations tested (data not
shown). Only the SiO2 (10) at the highest concentration
(132 μg/mL) significantly increased the concentrations of
IL-6 andMIP-2 compared with negative controls (Figure 4).4 hr and 24 hr post-exposure to ENM (100 μg) by oropharyngeal
=5-6 in each group). *p <0.05 compared with the saline-exposed
f LPS served as a positive control.
Figure 3 Cytokine levels in BALF of mice at 4 hr and 24 hr post-exposure to ENM (100 μg) by oropharyngeal aspiration. (A) IL-6, (B) MIP-2,
and (C) TNF-α concentrations in BALF. Data are means ± SEM (n =5-6 in each group). *p <0.05 compared with the saline-exposed negative
control group from the same time point. Mice exposed to 2 μg of LPS served as a positive control.
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was not statistically significant.
Assessment of the cell culture supernatant from ENM-
exposed MH-S cells at 24 hr post-exposure revealed that
all ENM increased the LDH release in a dose-dependent
manner (Figure 5A). SiO2 (10) and TiO2 (10 and 200)
appeared to be more and less cytotoxic, respectively, how-
ever no apparent size-dependent effects (on cell mem-
brane integrity) were observed. Half-maximal effective
concentrations (EC50) for the cell membrane integrity of
SiO2 (10), CeO2 (23), CeO2 (88), TiO2 (10), and TiO2
(200) were approximately 100, 295, 141, 330, and 384 μg/
mL, respectively. Cell viability based on the metabolicFigure 4 Cytokine levels in lung tissue slices at 24 hr post-exposure t
in the culture medium (CM) from the lung tissue slices. Data are means ± SEM
control group. Lung tissue slices exposed to 87 ng/mL of LPS served as a posactivity of mitochondria was assessed at 24 hr post-
exposure (Figure 5B). Similar to the LDH analysis data, we
also observed dose-dependent effects of ENM. EC50 for
the cell viability of SiO2 (10), CeO2 (23), CeO2 (88), TiO2
(10), and TiO2 (200) were approximately 13, 18, 55, 30,
and 77 μg/mL, respectively (Additional file 2: Figure S2).
Thus, toxicity ranking of ENM based on the EC50 for via-
bility was in the order of SiO2 (10) > CeO2 (23) > TiO2
(10) > CeO2 (88) > TiO2 (200). Because the EC50 was much
higher for LDH, this would indicate that the mitochondrial
function was more sensitive to ENM exposure than cell
membrane integrity. We also measured cell proliferation
based on DNA content at 24 hr post-exposure and foundo ENM (132 μg/mL). (A) IL-6, (B) MIP-2, and (C) TNF-α concentrations
(n =3 in each group). *p <0.05 compared with CM-exposed negative
itive control.
Figure 5 Biochemical markers for cell membrane damage, viability, and proliferation in MH-S cells at 24 hr post-exposure to ENM
(3.125-100 μg/mL). (A) LDH concentrations in the culture medium (CM) from the MH-S cells, (B) cell viability based on metabolic activity
of mitochondria, and (C) cell proliferation based on DNA content. Data are means ± SEM (n =3-6 in each group). *p <0.05 compared with
CM-exposed negative control group. MH-S cells exposed to 1% Triton X-100 served as a positive control.
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the ENM-exposed groups except at the high concentra-
tion exposure (Figure 5C). At 100 μg/mL concentration,
SiO2 (10) significantly decreased MH-S cell numbers,
while TiO2 (10) and TiO2 (200) significantly increased
the cell numbers. Concentrations of pro-inflammatory
cytokine, IL-6, in MH-S cells were measured at 24 hr
post-exposure (Figure 6). SiO2 (10) induced more IL-6
production than other ENM which was in line with the
IL-6 lung tissue slice response. To provide a more realistic
comparison, we converted the nominal mass media con-
centration (i.e., μg/mL) to mass per unit cell (or tissue)
surface area (i.e., μg/cm2) because lung tissue slices haveFigure 6 Cytokine level in MH-S cells at 24 hr post-exposure to ENM (3
compared with CM-exposed negative control group.a larger 3D surface area than the MH-S cells. Taking this
into account the exposure dose of 132 μg/mL to the
lung slice resulted in a dose of 4.7 μg/cm2. Therefore,
the IL-6 responses in MH-S cells exposed to 12.5 μg/mL
concentration (equivalent to 4.2 μg/cm2) was compar-
able to those in the lung tissue slices exposed to 132 μg/
mL concentration (see the Materials and Methods sec-
tion for a more detailed calculation).
Discussion
While much work is being done to better understand the
potential toxic effects of ENM on human health, it is still
not clear which physico-chemical parameters of ENM are.125-100 μg/mL). Data are means ± SEM (n =3 in each group). *p <0.05
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toxic potential of emerging ENM is likely to increase the
numbers of animals required, unless alternative methods
are available that consistently reflect the in vivo biological
effects. Here we utilized three different toxicity testing
methods (mice, mouse lung tissue slices, and alveolar
macrophages) to investigate the comparative toxicity of
five ENM (SiO2 (10), CeO2 (23), CeO2 (88), TiO2 (10), and
TiO2 (200)) and determine if the latter two techniques
could predict effects seen in animals. We found, in all
three different toxicity testing methods, that SiO2 (10)
and/or CeO2 (23) had the highest activity on the basis
of pro-inflammatory cytokine production. Importantly the
mouse lung tissue slices and alveolar macrophages exhib-
ited similar cytokine responses to the distinct ENM when
the exposure dose metric was based on cell surface area.
Size- and chemical composition-dependent lung toxicity
of ENM in mice
Numerous studies of nanotoxicology have shown that
toxicity of ENM is strongly influenced by two factors: 1)
chemical toxicity based on the chemical composition of
ENM, and 2) cellular stress caused by the physical prop-
erties of ENM [9]. In line with published reports, it was
evident that only the smaller-sized ENM caused signifi-
cant inflammatory effects on mouse lungs, and that the
chemical composition was important since stronger ef-
fects were noted in SiO2 (10) and CeO2 (23) but not
TiO2 (10). Interestingly TiO2 lung macrophage uptake
was higher than the other ENM, despite displaying lower
toxicity suggesting that the observed inflammatory re-
sponses were not dependent on phagocytosis. In support
of this, a similar study demonstrated that nanomaterial
toxicity was not correlated with particle uptake in the
cells [21].
Although further studies are needed to understand the
mechanism underlying lung toxicity of ENM, the data
also suggest that there was no clear relationship between
lung toxicity and degree of ENM agglomeration (i.e.,
hydrodynamic diameters). Agglomerates of ENM form
in biological fluids by loose binding (e.g., van der Waals
force) while primary diameters, and not hydrodynamic
diameters influence toxicity. In support of this, other
researchers have reported that nanoparticle trafficking
across lung epithelial cells was correlated with primary
diameters and not the hydrodynamic diameters of the
agglomerated nanoparticles [22].
Numerous studies have reported that ENM of various
crystalline forms and solubility cause varying degrees of
lung injury and inflammation. It is generally accepted
that insoluble ENM are far less active in producing cel-
lular damage or injury as compared to (partially) soluble
ENM of similar size [23-25], although insoluble ENM
have the potential to remain in the lungs and otherorgans for a long. It also should be noted that while
insoluble ENM may not be potent enough to cause cell
damage, crystallinity of the ENM (e.g., amorphous or
crystalline) might contribute to other toxicological prop-
erties [10,26]. In addition, insoluble ENM may cause
oxidative stress and lung inflammation depending on
their conduction band energy levels [27]. The ENM used
in this study (SiO2, CeO2, and TiO2) were insoluble (or
poorly soluble) in biological fluids and considered not to
release free ions from the nanomaterials to the tissue or
cells. Here, the cytokine responses induced by SiO2 (10)
and CeO2 (23) were evident in mice at 4 hr post-exposure
but receded to control levels at 24 hrs, indicating that
the inflammatory response was transient. Others have
reported sustained pro-inflammatory cytokine levels at
24 hrs after exposure to SiO2 (amorphous and 14 nm)
albeit with 50 mg/kg which is ~15 times higher than the
concentration used here [28]. While lung toxicity of
SiO2 nanomaterials has been extensively studied [26],
there are only a few reports of lung toxicity of CeO2
nanomaterials [9,29-32]. Moreover, these studies have
mainly focused on long-term toxicity in mice or rats,
demonstrating that intratracheal instillation or inhal-
ation of CeO2 nanomaterials led to severe chronic lung
inflammation for up to 28 day post-exposure. Although
our findings were limited to the 24 hr time-course, we
cannot rule out the possibility of further chronic inflam-
matory responses, particularly in light of human case stud-
ies which report development of lung disease in workers
after repeated long-term exposure of CeO2 [33,34]. Simi-
larly, our results showed that TiO2 nanomaterials did not
cause significant lung inflammation in mice, consistent
with recently published TiO2 toxicity findings performed
through multiple interlaboratory comparisons [35].
Comparing lung toxicity testing in mice to its alternatives
Efforts to reduce the number of animals in toxicity test-
ing have resulted in the development of numerous
ex vivo and in vitro toxicity test methods but the results
are still conflicting. This inconsistency could be due to
the fact that there are 1) a lack of overall consensus on
the relevant dose metric for in vivo and ex vivo/in vitro
studies and 2) inherent limitations to most in vitro
models such as a lack of complex cell-cell interactions
[36]. Here, the mouse lung tissue slices (ex vivo) and
MH-S cells (in vitro) displayed a similar pattern of cyto-
kine response on the basis of the mass per unit surface
area of cell or tissue (μg/cm2) but not per unit volume
of culture medium (μg/mL), suggesting that cell surface
area should be considered in in vitro dosimetry when
comparing toxicity endpoints from different systems.
It is well documented that nanomaterials form agglomer-
ates in suspension and their fate (or behavior) is governed
by different mass transport properties (sedimentation and/
Kim et al. Journal of Nanobiotechnology 2014, 12:47 Page 8 of 12
http://www.jnanobiotechnology.com/content/12/1/47or diffusion), leading to differential exposures of nano-
materials to cells [17,18,20]. The nominal mass media
concentration (μg/mL) in submerged cell-culture condi-
tions assumes that the suspended nanomaterials are
completely deposited on the cell surface which may not
be always true for all nanomaterials in suspension and
may result in misinterpretation of biological response
data [37]. In the present study the density of agglomerated
ENM in suspension (which influences delivered dose) was
associated with the resultant cellular responses ex vivo
and in vitro [17,18,20]. Notably, if the agglomerate density
approached the density of the culture medium, the nano-
materials were more likely to remain suspended in the
medium (i.e., low delivered dose), leading to a reduced
exposure and diminution of biological responses to the
nanomaterials [17,18]. In this regard, since the agglomer-
ate densities of SiO2 (10), CeO2 (23) and TiO2 (10) ex vivo
and in vitro were closer to the culture media compared to
other ENM, it is likely that the toxic effects were underes-
timated. In other words, the cytokine responses ex vivo
and in vitro would be expected to increase even more if
the cells were exposed to the same delivered dose. There-
fore, considering the behavior of ENM agglomerates in
submerged cell culture systems (ex vivo or in vitro) may
reduce the disparity between in vitro and in vivo nanotoxi-
cology outcomes. However, there are limitations to be
considered when interpreting in vitro cellular responses
based on agglomerate density. If ENM are soluble in
culture media, their agglomerate density will change over
time. Moreover, as described above, in the case of in vitro
ENM toxicity tests, agglomerations may result in an
underestimation of toxicity outcomes (or ranking), while
in the case of in vivo ENM toxicity tests (via intratracheal
instillation or oropharyngeal aspiration technique), ag-
glomeration may cause an overestimation of toxicity out-
comes (or ranking) [38]. It is also worth noting that the
agglomeration associated with ability of ENM to absorb
biological components (e.g., ions, salts, and proteins) in
the in vitro and in vivo system may differently overshadow
ENM properties (e.g., chemistry and surface charge), lead-
ing to the inconsistent results (in vitro versus in vivo) [39].
As aforementioned, one of the major challenges faced
in cell-based in vitro models is that intact lungs are
comprised of about 40 different cell types, and in vitro
models cannot wholly reflect the microenvironment of
cell-cell and cell-matrix interactions. Here we utilized
the lung tissue slice model which preserves the lung
architecture with nearly all cell types. We have previously
reported that mouse lung tissue slices incubated with size
fractionated particulate matter from a wildfire event dis-
played similar cytokine responses to those observed in
mice [40]. In line with this finding, the lung tissue slice
system also showed similar pro-inflammatory responses to
ENM as those seen in mice (i.e., pro-inflammatory effectsof SiO2 (10) and CeO2 (23) but not TiO2 (10)). Taken to-
gether, the results provide further evidence for particle-
mediated biological responses in lung tissue slices and the
feasibility of this application to lung toxicity testing. Al-
though several studies have demonstrated toxicity of
ENM in lung tissue slices [41,42], this is the first report to
our knowledge to compare responses to different size and
types of ENM in both mice and mouse lung tissue slices.
In addition, the rank order of ENM IL-6 production from
the MH-S cells was the same as that observed in both the
ex vivo and in vivo comparisons suggesting that lung
macrophages play an important role in this response. In
contrast, the response ranking for TNF-α (which is
expressed at lower levels in lung macrophages com-
pared to IL-6 [43]) was not the same, suggesting that
this biomarker would not be a good readout across the
three systems. It should be noted that lung epithelial
cells and macrophages differ in pro-inflammatory re-
sponses following exposure to ENM [44,45] and that
toxicity differs depending on the cell of origin [36], as
demonstrated by the observation that cancerous cells
are more toxic than their normal precursors.
Conclusions
We conclude that small-sized ENM, SiO2 (10) and CeO2
(23) but not TiO2 (10), caused acute lung toxicity in
mice (in vivo). CeO2 (23) had the strongest effect on
cytokine (IL-6, TNF-α, and MIP-2) release, neutrophil
recruitment, and increased protein into the mouse lungs,
while the larger CeO2 (88) and TiO2 (200) were less po-
tent, indicating that the effect was dependent on both
size and chemical composition of ENM. The rank order
of ENM toxicity from both lung tissue slices (ex vivo)
and alveolar macrophages (in vitro) corresponded well
to the ranking results from the mice (in vivo), suggesting
that lung macrophages could replicate this effect. The
similar profile of inflammatory response ex vivo and
in vitro was most apparent when the exposure was based
on mass per cell surface area. Although we demonstrated
a relatively good correlation among the acute lung toxicity
endpoints from three different testing methods, further
studies are still needed that measure reversibility of effects
or progression to long term toxicity. Nevertheless the
results provide further evidence for the feasibility of re-
placing animal lung toxicity testing with cells or lung
tissue slices, and provide information about the import-
ant parameters (e.g., agglomeration state and exposure
dose metric) that will improve interpretation of ENM
toxicity in biological systems.
Materials and methods
Experimental animals
Adult pathogen-free female CD-1 mice (~20-25 g and ~30-
45 g body weights for pulmonary toxicity and lung tissue
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Breeding Laboratories (Raleigh, NC). Mice were housed in
groups of five in polycarbonate cages with hardwood chip
bedding at the U.S. Environmental Protection Agency
(EPA) Animal Care Facility accredited by the Association
for Assessment and Accreditation of Laboratory Animal
Care and were maintained on a 12-hour light to dark cycle
at 22.3 ± 1.1°C temperature and 50 ± 10% humidity. Mice
were given access to rodent chow and water ad libitum
and were acclimated for at least 10 days before the study
began. The studies were conducted after approval by the
EPA Institutional Animal Care and Welfare Committee.Engineered nanomaterials (ENM)
Five ENM were used in this study and designated by
their mean primary diameter provided by the manufac-
turer: SiO2 (10) (silicon dioxide with a primary diameter of
5–15 nm; amorphous; Sigma Aldrich (St. Louis, MO)),
CeO2 (23) (cerium oxide with a primary diameter of 15–
30 nm; cerianite; NanoAmor (Houston, TX)), CeO2 (88)
(cerium oxide with a primary diameter of 70–105 nm; cer-
ianite; Alfa Aesar (Ward Hill, MA)), TiO2 (10) (titanium
dioxide with a primary diameter of 10 nm; anatase; Alfa
Aesar), and TiO2 (200) (titanium dioxide with a primary
diameter of 200 nm; anatase; Acros Organics (Fair Lawn,
NJ)). The ENM were suspended in saline for in vivo and
culture media (see below for further details) for ex vivo and
in vitro, followed by sonication (Sonicator 4000; Misonix
Sonicators, Newtown, CT) at 70–80 watts for 10 min and
vortex mixing for 1 min to yield a stock solution at a con-
centration of 2 mg/mL. The ENM suspensions were stored
at −80°C until toxicity testing. To explore the effect of
solution chemistry on hydrodynamic diameters of ENM,
dynamic light scattering (Zetasizer Nano ZS; Malvern
Instruments, Malvern, UK) was used at 100 μg/mL ENM
concentration in various solutions, such as distilled water,
saline, and culture media. Further detailed physicochemical
characteristics of ENM are presented in Table 1.In vivo toxicity of ENM
Mouse exposure to ENM
Oropharyngeal aspiration was performed on mice anesthe-
tized in a small plexiglass box using vaporized anesthetic
isofluorane, following a technique described previously
[46]. Briefly, the tongue of the mouse was extended with
forceps and 100 μg of ENM in 50 μL saline was pipetted
into the oropharynx. Immediately, the nose of the mouse
was then covered causing the liquid to be aspirated into
the lungs. Similarly, a separate group of mice was instilled
with 2 μg of lipopolysaccharide (LPS; Escherichia coli
endotoxin; 011:B4 containing 106 unit/mg material; Sigma)
as a positive control to demonstrate maximal responsive-
ness to this well characterized inflammatory agent whileadditional mice were instilled with 50 μL saline alone
as a negative control.
Bronchoalveolar lavage and hematology
At 4 hr and 24 hr post-exposure, six mice from each
treatment group were euthanized with 0.1 mL intraperi-
toneal injection of Euthasol (diluted 1:10 in saline;
390 mg pentobarbital sodium and 50 mg phenytoin/mL;
Virbac AH, Inc., Fort Worth, TX), and blood was col-
lected by cardiac puncture using a 1-mL syringe con-
taining 17 μL sodium citrate to prevent coagulation. The
trachea was then exposed, cannulated and secured with
suture thread. The thorax was opened and the left main-
stem bronchus was isolated and clamped with a micro-
hemostat. The right lung lobes were lavaged three times
with a single volume of warmed Hanks balanced salt
solution (HBSS; 35 mL/kg mouse). The recovered bron-
choalveolar lavage fluid (BALF) was centrifuged at 800xg
for 10 min at 4°C and the supernatant was stored at both
4°C (for biochemical analysis) and −80°C (for cytokine
analysis). The pelleted cells were resuspended in 1 mL
HBSS (Sigma). Total BALF cell count of each mouse was
obtained by a Coulter counter (Coulter Co., Miami, FL).
Additionally, 200 μL resuspended cells were centrifuged
in duplicate onto slides using a Cytospin (Shandon,
Pittsburgh, PA) and subsequently stained with Diff-Quik
solution (American Scientific Products, McGraw Park,
PA) for enumeration of macrophages and neutrophils with
at least 200 cells counted from each slide. Hematology
values including total white blood cells, total red blood
cells, hemoglobin, hematocrit, mean corpuscular volume,
mean corpuscular hemoglobin concentration, and plate-
lets were measured using a Coulter AcT 10 Hematology
Analyzer (Beckman Coulter Inc., Miami, FL).
Biochemical and cytokine analyses
Concentrations of lactate dehydrogenase (LDH) and γ-
glutamyl transferase (GGT) were determined using com-
mercially available kits (Thermo Scientific, Middletown,
VA). Albumin and total protein concentrations were
measured by the SPQ test system (DiaSorin, Stillwater,
MN) and the Coomassie plus protein assay (Pierce
Chemical, Rockford, IL) with a standard curve prepared
with bovine serum albumin (Sigma), respectively. Activity
of N-acetyl-β-D-glucoaminidase (NAG) was determined
using a NAG assay kit (Roche Applied Science, Indianapo-
lis, IN). All biochemical assays were modified for use on
the KONELAB 30 clinical chemistry spectrophotometer
analyzer (Thermo Clinical Lab Systems, Espoo, Finland)
as described previously [46]. Concentrations of tumor
necrosis factor-α (TNF-α), interleukin-6 (IL-6) and
macrophage inhibitory protein-2 (MIP-2) in BALF were
determined using commercial multiplexed fluorescent
bead-based immunoassays (Milliplex Map Kit, Millpore
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Co., Austin, TX) following the manufacturer’s protocol.
The limits of detection (LOD) of each cytokine were 6.27,
3.28 and 29.14 pg/mL for TNF-α, IL-6 and MIP-2, re-
spectively, and all values below these lowest values were
replaced with a fixed value of one-half of the LOD value.
Ex vivo toxicity of ENM
Mouse lung tissue slice preparation and incubation
Lung tissue slices were prepared as previously described
[40]. Briefly, mice were euthanized with 0.1 mL intraperito-
neal injection of Euthasol (diluted 1:10 in saline; Virbac
AH, Inc.). The trachea was exposed and cannulated using a
20G luer stub adapter (Instech Solomon, Plymouth Meet-
ing, PA). The lungs were filled with 1.5% (w/v) low-melting
agarose (Sigma) in minimum essential medium (MEM;
Simga) at 37°C. The lungs were rinsed with the ice-cold sli-
cing buffer solution (Earle’s balanced salt solution (Sigma)
supplemented with 15 mM N-(2-hydroxyethyl)piperazine-
N’-(2-ethanesulfonic acid) hemisodium salt (HEPES;
Sigma)) and removed from the mouse. The lungs were
transferred into the ice-cold slicing buffer solution to fur-
ther solidify the agarose and then the lung lobes were sep-
arated using a surgical blade, and the lung tissue cores
(8 mm diameter) were prepared using a tissue coring tool
(Alabama Research and Development, Munford, AL). Tis-
sue cores were cut into 350 μm thick slices in the ice-cold
slicing buffer solution using a specialized vibratome (OTS
5000, FHC Inc., Bowdoinham, ME). The lung tissue
slices were then incubated in the wash buffer solution
(Dulbecco’s modified eagle’s medium/nutrient mixture
F-12 Ham (Sigma) supplemented with 100 units/mL
penicillin (Sigma) and 100 μg/mL streptomycin (Sigma))
under cell culture conditions for 4 hrs. The lung tissue
slices were then transferred into a tissue culture treated
polystyrene 48-well plate (Corning Inc., Corning, NY)
and cultured in the slice incubation medium (the wash
buffer solution supplemented with 200 mM L-glutamine
(Sigma), 0.1 mM MEM non-essential amino acids (Sigma)
and 15 mM HEPES) for up to 6 days at 37°C in a humidi-
fied atmosphere of 5% CO2 and 95% air. The lung tissue
slices received fresh media every day.
Mouse lung tissue slice exposure to ENM
Reconstituted ENM suspensions were sonicated for 2 min,
vortexed for 1 min and further diluted with the slice incu-
bation medium to achieve final concentrations of 22, 44,
66, and 132 μg/mL. On day 2 of culture, lung tissue slices
were exposed to the ENM for 24 hrs. The initial concentra-
tion of 22 μg/mL (total volume of 0.5 mL, therefore of
11 μg of ENM per lung slice) was estimated to be five times
higher than the in vivo exposure dose used in this study. If
it is assumed that the lung surface area of a 20 g mouse
is ~650 cm2, 1 cm3 mouse lung tissue has ~800 cm2 lungsurface area, and 100% of oropharyngeal instilled ENM
is delivered to the lungs, 100 μg of ENM dose in a
mouse (~650 cm2 lung surface area) is equivalent to
2.2 μg of ENM dose in a mouse lung slice (~14 cm2 lung
slice surface area) [47]. Moreover, if it is assumed that
the lung slice surface area is ~14 cm2, the exposure
doses of 22, 44, 66, and 132 μg/mL are equivalent to the
doses of 0.79, 1.6, 2.3, and 4.7 μg/cm2, respectively.
Mouse lung tissue slices were exposed to 87 ng/mL LPS
which was an equivalent concentration in vivo and
served as a positive control. Mouse lung tissue slices ex-
posed to the culture medium alone served as a negative
control. At 24 hr post-exposure, lung slice culture fluids
were collected, centrifuged at 10,000xg for 5 min, and
culture supernatants were stored at both 4°C (for extra-
cellular biochemical analysis) and −80°C (for cytokine
analysis). Subsequently, mouse lung tissue slices were
homogenized using a tissue homogenizer in a lysis buffer
solution containing 0.5% Triton X-100, 150 mM NaCl,
15 mM Tris–HCl (pH 7.4), 1 mM CaCl2 and 1 mM
MgCl2 [48]. Homogenates were then centrifuged at
10,000xg for 10 min and supernatants were stored at −80°C
(for intracellular biochemical analysis).
Biochemical and cytokine analyses
Similar to the in vivo lung inflammation analyses described
above, the supernatants of tissue culture fluids and tissue
homogenates after exposure to ENM were used to de-
termine the extracellular (LDH and NAG) and intracel-
lular (GGT) biochemical analyses as well as cytokine
analysis (IL-6, MIP-2, and TNF-α). Biochemical and pro-
inflammatory cytokine analyses were performed using a
KONELAB 30 clinical chemistry spectrophotometer
analyzer (Thermo Clinical Lab Systems) and multiplexed
fluorescent bead-based immunoassays (Milliplex Map Kit)
measured by the Luminex 100 (Luminex Co).
In vitro toxicity of ENM
Alveolar macrophage cell culture
The murine alveolar macrophages (MH-S) cells were pur-
chased from ATCC (CRL2019, Manassas, VA) and grown
in the following culture medium: RPMI 1640 (Sigma) sup-
plemented with 5% fetal bovine albumin (FBS; Sigma) and
100 units/mL penicillin (Sigma) and 100 μg/mL strepto-
mycin (Sigma) at 37°C in a humidified atmosphere of 5%
CO2 and 95% air. MH-S cells at passage 11 yielded 2.4 -
2.9 × 106 cells/mL and were seeded at 3,000 cells per well
of a 96-well culture plate.
Alveolar macrophage cell exposure to ENM
After 3 days in culture, MH-S cells were exposed to
ENM at final concentrations of 3.125, 6.25, 12.5, 25, 50,
and 100 μg/mL in the culture medium for 24 hrs. This
exposure dose can be converted to the dose based on
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0.3 cm2). Thus, the exposure doses of 3.125, 6.25, 12.5,
25, 50, and 100 μg/mL are equivalent to the doses of 1.0,
2.1, 4.2, 8.3, 16.7, and 33.3 μg/cm2, respectively. MH-S
cells exposed to the culture medium alone served as a
negative control and 1% Triton X-100 at 37°C served as
a positive control.
Biochemical and cytokine analyses
After the cells exposed to ENM, the plate was centrifuged
at 400xg for 5 min, followed by collection of supernatants
to analyze LDH concentrations. The supernatants were
also used to determine cytokine production (IL-6). The
MH-S cells after centrifugation were then used to evaluate
cell proliferation (CyQuant assay; Invitrogen, Eugene,
OR). Viability of the MH-S cells exposed to ENM was
tested by measuring enzymatic activity based on the cellu-
lar cleavage of water-soluble tetrazolium salt (WST-1) to
formazan in the cells using a WST-1 assay kit (Roche
Applied Science). Biochemical and pro-inflammatory
cytokine analyses in this study were also performed using
a KONELAB 30 clinical chemistry spectrophotometer
analyzer (Thermo Clinical Lab Systems) and multiplexed
fluorescent bead-based immunoassays (Milliplex Map Kit)
measured by the Luminex 100 (Luminex Co).
Statistical analysis
Data were expressed as means ± the standard error of the
mean (SEM). The results of the ENM-exposed groups
were compared to those of the negative control group.
Statistical comparison was performed by one-way analysis
of variance (ANOVA) with the Newman-Keuls post-hoc
test. Statistical analyses were performed using commercial
software (GraphPad Prism 6.04, GraphPad Software, Inc.,
San Diego, CA). If the data did not meet the ANOVA as-
sumptions of either normality or equal variances (Levene’s
test; p >0.05), the data were transformed. Subsequent to
the transformation, the data were checked for require-
ment compliance and if acceptable, ANOVA proceeded.
The statistical significance level was assigned at a prob-
ability value of p <0.05.
Additional files
Additional file 1: Figure S1. Representative BAL cell images at 4 hr and
24 hr post-exposure to ENM. Red arrows indicate ENP uptakes in alveolar
macrophages. Original magnification (20x), inset (40x).
Additional file 2: Figure S2. Dose–response curves to determine EC50
values for the MH-S cells from WST-1 assay data.
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